1Makino H, Kashihara N, Sugiyama H, et al. Phenotypic changes of the mesangium in diabetic nephropathy[J ]. J Diabetes Compl,1995, 9:282-284.
2Buckingham RE, Al-Barazanji KA, Toaeland CDN, et al. Peroxisome proliferator-activated reeeptor-γ agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zueker fatty rats[ J ]. Diabetes, 1998, 47 : 1326-1334.
3Yoahimoto T, Naruse M, Nishikawa M, et al. Antihypertensive and vasculo and renoprotective effects of pioglitazone in genetically obese diabetic rats [ J ]. Am J Physiol, 1997, 272 : E989-E996.
